Medical News Hubb
Advertisement
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us
No Result
View All Result
Medical News Hubb
No Result
View All Result
Home News

Neuropathy Drives Hypoglycemia Cluelessness in T1D

admin by admin
August 1, 2022
in News


Researchers published the study covered in this summary on researchsquare.com as a preprint that has not yet been peer reviewed.

Key Takeaways

  • In Japanese adults with type 1 diabetes insulin-pump treatment (continuous subcutaneous insulin infusion) and higher problem-solving perception appear protective against impaired awareness of hypoglycemia (IAH), while diabetic peripheral neuropathy (DPN) is associated with increased risk.

  • Diabetes distress and fear of hypoglycemia are common in people with IAH.

Why This Matters

  • Adults with type 1 diabetes and IAH have a reduced ability to perceive hypoglycemic symptoms and are at risk of severe hypoglycemic events because they are unable to take immediate corrective action.

  • This is the first study to identify protective factors and risk factors of IAH in Japanese adults with type 1 diabetes.

  • People with IAH may plan to loosen tight glucose management and intentionally omit insulin injection to prevent severe hypoglycemia.

  • The information in this report may help improve the management of people with problematic hypoglycemia, the authors suggested. Treatment with an insulin pump and structured education aimed at improving problem-solving skills may be useful interventions for adults with type 1 diabetes and IAH, they suggested.

Study Design

  • The study involved a cross-sectional analysis of 288 Japanese adults with type 1 diabetes who averaged 50 years old, had diabetes for an average of about 18 years, had an average A1c at baseline of 7.7%, and included about 37% men and 63% women.

  • The cohort included 55 people with IAH (19%) and 233 with no impairment of their hypoglycemia awareness, based on their score on the Clarke questionnaire.

Key Results

  • DPN was significantly more prevalent in the IAH group than in the control group (12.0% vs 26.5%). A logistic regression analysis showed that the odds ratio for DPN was 2.63-fold higher among people with IAH compared with those without IAH, but there were no differences in other complications or by A1c levels.

  • Treatment with continuous subcutaneous insulin therapy (an insulin pump) was significantly less prevalent in the IAH group compared with those without IAH (23.6% vs 39.5%), with an adjusted odds ratio of 0.48. The two subgroups showed no differences in use of continuous glucose monitoring, used by 56% of the people in each of the two subgroups.

  • The two subgroups showed no differences in their healthy lifestyle score, sleep debt, or rates of excessive drinking.

  • Mean autonomic symptom scores for both sweating and shaking were significantly reduced in the IAH group, but no between-group differences appeared for palpations or hunger.

  • All mean neuroglycopenic symptom scores were significantly lower in those without IAH, including confusion and speech difficulty.

  • Scores for measures of diabetes distress and for the worry component of the fear-of-hypoglycemia were significantly higher in the IAH group, but there were no differences in other psychological measures.

  • Higher hypoglycemia problem-solving perception scores were significantly associated with decreased IAH risk with a calculated odds ratio of 0.54, but other aspects of hypoglycemia problem-solving such as detection control, goal setting, and strategy evaluation showed no significant links.

Limitations

  • The study used a cross-sectional design, which is not suited to making causal inferences.

  • The authors characterized DPN as either present or absent. They did not evaluate or analyze the severity of peripheral neuropathy.

  • The authors evaluated diabetic cardiac autonomic neuropathy (DCAN) by a person’s coefficient of variation of R-R intervals, and definitive diagnosis of DCAN required at least two positive results on a cardiac autonomic test. More vigorous evaluation using a more definitive assessment of DCAN is needed to relate DCAN and IAH status.

Disclosures

This is a summary of a preprint research study, “Protective and risk factors of impaired awareness of hypoglycemia in patients with type 1 diabetes: a cross- sectional analysis of baseline data from the PR-IAH study,” written by researchers at several hospitals in Japan, all affiliated with the National Hospital Organization, on Research Square brought to you by Medscape. The study has not yet been peer-reviewed. The full text of the study can be found on researchsquare.com.


Credits:

Lead Image: One Photo/Dreamstime

Cite this: Miriam E. Tucker. Neuropathy Drives Hypoglycemia Cluelessness in T1D – Medscape – Aug 01, 2022.



Source link

Tags: A1Cacute memory disordersconfusional statescontinuous subcutaneous insulin infusiondiabetes mellitusdiabetes mellitus type 1diabetes mellitus type idiabetic control indexdisease managementGHbglycated hemoglobinglycohemoglobinglycosylated hemoglobinHb1cHbA1chemoglobin A1chemoglobin A1c testhypoglycemiainsulin pumpType 1 diabetesuncontrolled diabetes mellitus type i
Previous Post

Study Investigating Oral JAK Inhibitor for Alopecia Areata Meets Endpoint

Next Post

Biden Recovering After Another Positive COVID Test

Next Post

Biden Recovering After Another Positive COVID Test

Recommended

Is the Latest Polio Scare Actually Caused by the Vaccine?

August 16, 2022

Summer Flu, RSV in July, ‘Super Colds’?

August 1, 2022

Don't miss it

Medicines & Healthy Lifestyle

Astaxanthin: The Super Antioxidant That Comes From the Ocean

August 19, 2022
Pharmaceutical

Health Bulletin 19/August/2022

August 19, 2022
Medicines & Healthy Lifestyle

Fezolinetant NDA Accepted for Vasomotor Symptoms With Menopause

August 19, 2022
Medicines & Healthy Lifestyle

Think You Avoided Omicron? Think Again. Here’s Why You May Have Been Infected

August 19, 2022
News

COVID Healthcare; Hypertension Risk; and Opioid Therapy

August 19, 2022
Pharmaceutical

Investing in health workers can help close the vaccination gap

August 19, 2022

© 2022 Medical News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.

Navigate Site

  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

Newsletter Sign Up

No Result
View All Result
  • Home
  • News
  • Pharmaceutical
  • Medicines & Healthy Lifestyle
  • Contact us

© 2022 Medical News Hubb All rights reserved.